Abemaciclib improved progression-free survival at 6 months in meningiomas with NF2 or CDK pathway alterations, achieving a 58 ...

Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...

Adolescent and adult women who use the synthetic progestogen chlormadinone acetate (CMA) have an elevated risk for intracranial meningioma, particularly if they use a high dose. However, the risk ...

Khaberni - A recent clinical study revealed promising results for a medication that may help slow the growth of aggressive meningioma, among the most challenging brain tumors to treat ...

Researchers have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most aggressive form of this common brain tumor. Researchers at Baylor College of Medicine and ...

Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of developing a type of brain tumor called an intracranial ...

In recent years, several major medical studies have identified a potential association between the Depo-Provera birth control shot and the development of meningioma brain tumors. Meningioma is ...